English
Адъювант-ассоциированная системная красная волчанка с уртикарным васкулитом и формированием саркоидоподобных гранулем
DOI: https://dx.doi.org/10.18565/therapy.2023.1.89-99
И.З. Гайдукова, Т.Э. Скворцова, С.Л. Воробьев
1) ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава России, г. Санкт-Петербург; 2) СПб ГБУЗ «Клиническая ревматологическая больница № 25», г. Санкт-Петербург; 3) ООО «Национальный Центр клинической морфологической диагностики», г. Санкт-Петербург
Литература
1. Shoenfeld Y., Agmon-Levin N. ASIA – Autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011; 36(1): 4–8. https://dx.doi.org/10.1016/j.jaut.2010.07.003. 2. Carvalho J.F., Barros S.M., Branco J.C., Fonseca J.E. ASIA or Shoenfeld’s syndrome: Highlighting different perspectives for diffuse chronic pain. Acta Reumatol Port. 2011; 36(1): 10–12. 3. Meroni P.L. Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): Old truths and a new syndrome? J Autoimmun. 2011; 36(1): 1–3. https://dx.doi.org/10.1016/j.jaut.2010.10.004. 4. Watad A., Quaresma M., Brown S. et al. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome) – An update. Lupus. 2017; 26(7): 675–81. https://dx.doi.org/10.1177/0961203316686406. 5. Jara L.J., Garcia-Collinot G., Medina G. et al. Severe manifestations of autoimmune syndrome induced by adjuvants (Shoenfeld’s syndrome). Immunol Res. 2017; 65(1): 8–16. https://dx.doi.org/10.1007/s12026-016-8811-0. 6. Watad A., Quaresma M., Bragazzi N.L. et al. The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/Shoenfeld’s syndrome: Descriptive analysis of 300 patients from the international ASIA syndrome registry. Clin Rheumatol. 2018; 37(2): 483–93. https://dx.doi.org/10.1007/s10067-017-3748-9. 7. Israeli E., Agmon-Levin N., Blank M., Shoenfeld Y. Adjuvants and autoimmunity. Lupus. 2009; 18(13): 1217–25.https://dx.doi.org/10.1177/0961203309345724. 8. Hogen Esch H. Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine. 2002; 20(Suppl 3): S34–S39. https://dx.doi.org/10.1016/s0264-410x(02)00169-x. 9. Perricone C., Colafrancesco S., Mazor R.D. et al. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun. 2013; 47 :1–16.https://dx.doi.org/10.1016/j.jaut.2013.10.004. 10. Zafrir Y., Agmon-Levin N., Paz Z. et al. Autoimmunity following hepatitis B vaccine as part of the spectrum of ‘Autoimmune (Auto-inflammatory) syndrome induced by adjuvants’ (ASIA): Analysis of 93 cases. Lupus. 2012; 21(2): 146–52.https://dx.doi.org/10.1177/0961203311429318. 11. Flores-Padilla G., Mora-Mendoza B., Pedraza-Montenegro A. Adjuvant induced autoimmune/inflammatory syndrome presenting as jointand lung manifestations. Reumatol Clin. 2014; 10(6): 406–8. https://dx.doi.org/10.1016/j.reumae.2014.01.007. 12. Kivity S., Katz M., Langevitz P. et al. Autoimmune syndrome induced by adjuvants (ASIA) in the Middle East: Morphea following silicone implantation. Lupus. 2012; 21(2): 136–39. https://dx.doi.org/10.1177/0961203311429551. 13. Segal Y., Dahan S., Sharif K. et al. The value of autoimmune syndrome induced by adjuvant (ASIA) – Shedding light on orphan diseases in autoimmunity. Autoimmun Rev. 2018; 17(5): 440–48. https://dx.doi.org/10.1016/j.autrev.2017.11.037. 14. Narins R.S., Beer K. Liquid injectable silicone: A review of its history, immunology, technical considerations, complications, and potential. Plast Reconstr Surg. 2006; 118(3 Suppl.): 77s–84s. https://dx.doi.org/10.1097/01.prs.0000234919.25096.67. 15. Schaefer C.J., Wooley P.H. The influence of silicone implantation on murine lupus in MRL lpr/lpr mice. J Rheumatol. 1999; 26(10): 2215–21. 16. Schaefer C.J., Whalen J.D., Knapp T., Wooley P.H. The influence of silicone implantation on type II collagen-induced arthritis in mice. Arthritis Rheum. 1997; 40(6): 1064–72. https://dx.doi.org/10.1002/art.1780400611. 17. Ameratunga R., Langguth D., Hawkes D. Perspective: Scientific and ethical concerns pertaining to animal models of autoimmune/ autoinflammatory syndrome induced by adjuvants (ASIA). Autoimmun Rev. 2018; 17(5): 435–39.https://dx.doi.org/10.1016/j.autrev.2017.11.033. 18. Cohen Tervaert J.W., Kappel R.M. Silicone implant incompatibility syndrome (SIIS): A frequent cause of ASIA (Shoenfeld’s syndrome). Immunol Res. 2013; 56(2–3): 293–98. https://dx.doi.org/10.1007/s12026-013-8401-3. 19. Lee S., Hayashi H., Maeda M. et al. Environmental factors producing autoimmune dysregulation – Chronic activation of T cells caused by silica exposure. Immunobiology. 2012; 217(7): 743–48. https://dx.doi.org/10.1016/j.imbio.2011.12.009. 20. Kaiser W., Biesenbach G., Stuby U. et al. Human adjuvant disease: Remission of silicone induced autoimmune disease after explanation of breast augmentation. Ann Rheum Dis. 1990; 49(11): 937–38. https://dx.doi.org/10.1136/ard.49.11.937. 21. Caldeira M., Ferreira A.C. Siliconosis: Autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Isr Med Assoc J. 2012; 14(2): 137–38. https://dx.doi.org/10.3389/fendo.2016.00150. 22. van Nunen S.A., Gatenby P.A., Basten A. Post-mammoplasty connective tissue disease. Arthritis Rheum. 1982; 25(6): 694–97.https://dx.doi.org/10.1002/art.1780250613. 23. Parks C.G., Conrad K., Cooper G.S. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect. 1999; 107(Suppl. 5): 793–802. https://dx.doi.org/10.1007/s11926-004-0011-6. 24. Tervaert J.W., Stegeman C.A., Kallenberg C.G. Silicon exposure and vasculitis. Curr Opin Rheumatol. 1998; 10(1): 12–17. 25. Hajdu S.D., Agmon-Levin N., Shoenfeld Y. Silicone and autoimmunity. Eur J Clin Invest. 2011; 41(2): 203–11.https://dx.doi.org/10.1111/j.1365-2362.2010.02389.x. 26. Jara L.J., Medina G., Gomez-Banuelos E. et al. Still’s disease, lupus-like syndrome, and silicone breast implants. A case of «ASIA» (Shoenfeld’s syndrome). Lupus. 2012; 21(2): 140–45. https://dx.doi.org/10.1177/0961203311430970. 27. Csako G., Costello R., Shamim E.A. et al. Serum proteins and paraproteins in women with silicone implants and connective tissue disease: a case-control study. Arthritis Res Ther. 2007; 9(5): R95. https://dx.doi.org/10.1186/ar2295. 28. Michaels B., Michaels J., Mobini N. Prominent lymphoid infiltrate with a pseudolymphoma-like morphology: A new histological finding of injectable liquid silicone. J Cutan Pathol. 2009; 36(11): 1224–26. https://dx.doi.org/10.1111/j.1600-0560.2009.01328.x. 29. Colafrancesco S., Perricone C., Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants and Sjogren’s syndrome. Isr Med Assoc J. 2016; 18(3–4): 150–53. 30. Harel M., Shoenfeld Y. Predicting and preventing autoimmunity, myth or reality? Ann N Y Acad Sci. 2006; 1069: 322–45.https://dx.doi.org/10.1196/annals.1351.031. 31. Janowsky E.C., Kupper L.L., Hulka B.S. Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases. N Engl J Med. 2000; 342(11): 781–90. https://dx.doi.org/10.1056/nejm200003163421105. 32. Colaris M.J., de Boer M., van der Hulst R.R., Cohen Tervaert J.W. Two hundreds cases of ASIA syndrome following silicone implants: A comparative study of 30 years and a review of current literature. Immunol Res. 2017; 65(1): 120–28.https://dx.doi.org/10.1007/s12026-016-8821-y. 33. Maijers M.C., de Blok C.J., Niessen F.B. et al. Women with silicone breast implants and unexplained systemic symptoms: a descriptive cohort study. Neth J Med. 2013; 71(10): 534–40. 34. Soriano A., Butnaru D., Shoenfeld Y. Long-term inflammatory conditions following silicone exposure: the expanding spectrum of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Clin Exp Rheumatol. 2014; 32(2):151–54. 35. Brown S.L., Pennello G., Berg W.A. et al. Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women. J Rheumatol. 2001; 28(5): 996–1003. 36. Kappel R.M., Pruijn G.J. The monobloc hydrogel breast implant, experiences and ideas. Eur J Plast Surg. 2012; 35(3): 229–33.https://dx.doi.org/10.1007/s00238-011-0591-0. 37. Exley C., Siesjo P., Eriksson H. The immunobiology of aluminium adjuvants: How do they really work? Trends Immunol. 2010; 31(3): 103–9. https://dx.doi.org/10.1016/j.it.2009.12.009. 38. Di Pasquale A., Preiss S., Tavares Da Silva F., Garcon N. Vaccine adjuvants: From 1920 to 2015 and beyond. Vaccines (Basel). 2015; 3(2): 320–43. https://dx.doi.org/10.3390/vaccines3020320. 39. McGarvey P.B., Suzek B.E., Baraniuk J.N. et al. In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases. BMC Immunol. 2014; 15: 61. https://dx.doi.org/10.1186/s12865-014-0061-0.
Об авторах / Для корреспонденции
Инна Зурабиевна Гайдукова, д.м.н., профессор, зам. директора НИИ ревматологии, профессор кафедры терапии, ревматологии, экспертизы временной нетрудоспособности и качества медицинской помощи им. Э.Э. Эйхвальда ФГБОУ ВО «Северо-Западный государственный медицинский университет
им. И.И. Мечникова» Минздрава России, врач-ревматолог СПб ГБУЗ «Клиническая ревматологическая больница № 25». Адрес: 191014, г. Санкт-Петербург, ул. Кирочная, д. 41. E-mail: ubp1976@list.ru. ORCID: https://orcid.org/0000-0003-3500-7256. SPIN-код: 3083-7996
Татьяна Эдуардовна Скворцова, к.м.н., доцент кафедры пропедевтики внутренних болезней, гастроэнтерологии и диетологии им. С.М. Рысса ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава России. Адрес: 191015, г. Санкт-Петербург, Пискаревский пр., д. 47,
пав. 24. E-mail: Tatyana.Skvortcova@szgmu.ru. ORCID: https://orcid.org/0000-0002-9362-9961
Сергей Леонидович Воробьев, к.м.н., врач-патологоанатом высшей категории, руководитель направлений морфологической диагностики онкологических заболеваний, болезней желудочно-кишечного тракта, эндокринных органов, супервайзер ООО «Национальный Центр клинической морфологической диагностики». Адрес: 192283, г. Санкт-Петербург, ул. Олеко Дундича, д. 8
